Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates
© Neva Press, Inc. 2005 |
|
CNS Drug ReviewsTable
of Contents
Volume 3, No. 2
| 103 |
|
Linopiridine:
Pharmacology of a Neurotransmitter Release Enhancer
Robert Zaczek, Robert J. Chorvat and Barry S. Brown |
| 120 |
|
Iloperidone:
Preclinical Profile and Early Clinical Evaluation
R. Corbett, L. Griffiths, J. E. Shipley, U. Shukla, J. T. Strupczewski, A. M.
Szczepanik, M. R. Szewczak, D. J. Turk, H. M. Vargas, S. Kongsamut and members of the
Iloperidone Project Team |
| 148 |
|
SR 57746A: An
Orally Active Non-Peptide Compound With Neurotrophic and Neuroprotective Effects
J. Fournier, P. E. Keane, P. Ferrara and P. Soubrié |
| 168 |
|
AHN649:
Preclinical Evaluation of a Novel Anticonvulsant and Neuroprotective Analog of
Dextromethorphan
Frank C. Tortella, Xi-Chun, M. Lu, Amy H. Newman and Paul Britton |
| 181 |
|
Anapsos:
Neuroimmunotrophic Treatment in Alzheimer Disease and Neurodegenerative Disorders
Antón Alvarez, José J. Miguel-Hidalgo, Lucia Fernández-Novoa, Joaquin Diaz, José
M. Sempere and Ramón Cacabelos |
|
|
|